Alto Neuroscience, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | 50.7% | 58.7% | -41.9% |
| FY2024 | -40.6% | -38.0% | -34.6% |
| FY2025 | -41.8% | -37.8% | -34.2% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | 50.7% | 58.7% | -41.9% |
| FY2024 | -40.6% | -38.0% | -34.6% |
| FY2025 | -41.8% | -37.8% | -34.2% |